Search clinical trials for: Cancer Risk

Total 98642 results

National Cancer Institute (NCI)

Not yet recruiting

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

Breast Carcinoma | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Breast Atypical Hyperplasia

United States
Anhui Provincial Hospital
Zhongda Hospital; Yijishan Hospital of Wannan Medical College; Wuhu City Second...

Recruiting

Conducting Active Surveillance Without Prostate Biopsy for Patients With Low-risk Suspected Prostate Cancer (ASWBP)

Prostate Cancer

China
AstraZeneca

Recruiting

A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA (ERA)

Breast Cancer

Russian Federation
IRCCS San Raffaele

Recruiting

24 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate Cancer (PRO-FAST)

Localized Prostate Carcinoma

Italy
FutureChem

Recruiting

[18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer

High Risk Prostate Carcinoma

Korea, Republic of
Merck Sharp & Dohme LLC
ModernaTX, Inc.

Recruiting

A Clinical Study of V940 Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

Melanoma

Spain, Italy, Poland, Australia, Chile, Canada, Portugal, Turkey, Germany, Greece, Israel, Sweden, New Zealand, United States, Belgium, France, Taiwan, United Kingdom, South Africa, Denmark, Argentina, Brazil, Colombia, Japan, Switzerland
Fondazione Policlinico Universitario Agostino Gemelli...
University of Bologna

Not yet recruiting

Genomic and Dietary Aspects in Gastric Cancer Risk (GenoStoP)

Gastric Cancer

Italy
Comprehensive Cancer Centre The Netherlands

Recruiting

High-Risk prostatE Cancer radiatiOn Versus surgERy (RECOVER)

Prostate Cancer | Prostate Adenocarcinoma

Netherlands
VA Office of Research and Development

Recruiting

The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS) (ProGRESS)

Prostate Cancer

United States
Institute of Hematology & Blood Diseases Hospital...
Beijing Health Alliance Charitable Foundation

Recruiting

The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes

Lower Risk MDS Per IPSS-R

China
Cedars-Sinai Medical Center
National Cancer Institute (NCI)

Not yet recruiting

NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making

Prostate Cancer
Zhejiang Cancer Hospital

Recruiting

Lenvatinib Combined With Tislelizumab and TACE Applied as Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma With High-risk Recurrence Factors

Hepatocellular Carcinoma | Oxaliplatin | TACE | Lenvatinib | Tislelizumab | Pharmorubicin

China
University of Oklahoma

Recruiting

Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy (OU-SCC-NCAN)

Lymphoma | Breast Cancer

United States
Regina Elena Cancer Institute
Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Weizmann Institute... and other collaborators

Recruiting

Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus

Liquid Biopsy | Squamous Cell Carcinoma of the Oropharynx | Lymph Node Metastasis | Carcinomas of Unknown Primary Site | High-risk Human Papillomavirus Infection | Occult Tumor of the Head and Neck Area

Italy
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix (NETkids)

Neoplasms | Appendix Cancer

Netherlands
Incyte Corporation

Recruiting

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease (THRIVE)

cGVHD

United States
National Cancer Institute (NCI)

Recruiting

Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes

Myelodysplastic Syndromes

United States
Turku University Hospital

Recruiting

Neoadjuvant ADT With TULSA in the Treatment of Intermediate Risk Prostate Cancer (NeoADT-TULSA)

Prostate Cancer | Localized Prostate Carcinoma | Intermediate Risk Prostate Cancer | Castration-Naive Prostate Cancer

Finland
Piazza della Vittoria 14 Studio Medico - Ginecologia...

Not yet recruiting

Perception About Benefits and Risks Related to Combined Hormonal Contraceptives Use in Patients With Lynch Syndrome

Lynch Syndrome | Contraception

Italy
Royal Marsden NHS Foundation Trust
University of Leeds

Recruiting

EVEREST-HN 1: EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem

Head and Neck Cancer

United Kingdom
Jasper Therapeutics, Inc.

Recruiting

JSP191 (Briquilimab) in Subjects With LR-MDS

Lower-risk Myelodysplastic Syndrome

United States
German Cancer Research Center
German Federal Ministry of Education and Research; University Hospital Heidelberg

Recruiting

COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer (COGNITION)

Neoadjuvant Therapy | Early-Stage Breast Cancer

Germany
Fudan University

Recruiting

TCb vs EC-T in High Risk ER+/HER2- Breast Cancer

Hormone Receptor Positive HER-2 Negative Breast Cancer

China
Massachusetts General Hospital
Agency for Healthcare Research and Quality (AHRQ)

Recruiting

Lung Cancer Screening in High-risk Black Women

Lung Cancer | Lung Carcinoma

United States
Sun Yat-sen University

Recruiting

Construction and Validation of Risk Prediction Model for Gastrointestinal Dysfunction of Patient With Colorectal Cancer

Surgery | Patient With Colorectal Cancer

China
Ankara Ataturk Sanatorium Training and Research...

Recruiting

The Effect of Nutritional Risk Parameters on Postoperative Pulmonary Complications in Geriatric Thoracic Surgery Cases

Postoperative Complications | Lung Cancer | Nutrition, Healthy

Turkey
Sun Yat-sen University

Recruiting

HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial

Hepatocellular Carcinoma

China
Zunyi Medical College

Recruiting

Development and Validation of a Risk Prediction Model for Preoperative Frailty in Elderly Patients With Colorectal Cancer

Colorectal Cancer

China
Nanfang Hospital, Southern Medical University
Shanghai Junshi Bioscience Co., Ltd.

Recruiting

Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer

Rectal Cancer | MSS | Locally Advanced | High-Risk

China
Sixth Affiliated Hospital, Sun Yat-sen University
Shanghai Weihe Medical Laboratory Co., Ltd.

Not yet recruiting

PRediction Of Five Usual Tumors Using Blood Test for Risk Assessment and Early Detection (PROFUTURE)

Neoplasms | Cancer

China
Ruijin Hospital

Recruiting

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) (dSEARCH)

Carcinoma, Hepatocellular | Hepatitis C, Chronic | Hepatitis B, Chronic | Cirrhosis, Liver | Non-Alcoholic Fatty Liver Disease

China
Duke University

Recruiting

Healthy Lifestyles After Cancer for Adolescents and Young Adults: A Program to Reduce Cardiovascular Risk Factors (HEALTHY-AYA)

Cardiovascular Diseases | Pain | Cancer | Fatigue | Weight Management | Distress, Emotional | Physical Inactivity

United States
Peter MacCallum Cancer Centre, Australia

Recruiting

Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (± Navitoclax) in Relapsed/Refractory Mantle Cell Lymphoma

Mantle Cell Lymphoma Refractory

Australia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.

Hepatocellular Carcinoma

China
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma

Mantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | Pleomorphic Variant Mantle Cell Lymphoma

United States
Geisinger Clinic

Recruiting

Mammogram Mail- and Phone-based Interventions

Breast Cancer

United States
Istituti Clinici Scientifici Maugeri SpA
Merck Sharp & Dohme LLC

Recruiting

Pembrolizumab in High-risk Thyroid Cancer (NePenThe)

Differentiated Thyroid Cancer

Italy
Maastricht University Medical Center
Rising Tide Foundation

Not yet recruiting

Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas (PROMISE-P)

Postoperative Complications | Surgery | Pancreas Cancer | Prehabilitation

Netherlands
Ottawa Hospital Research Institute
Knight Therapeutics (USA) Inc

Recruiting

Dose Escalation For INtraprostatic LEsions (DEFINE)

Prostatic Neoplasms

Canada
Precision Health Equity Initiative

Not yet recruiting

The RISC Registry--Risk Informed Screening Registry (RISC)

Breast Cancer Risk

United States
Technische Universität Dresden
German Cancer Research Center; KKS Dresden

Not yet recruiting

Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula (XandTX)

Periampullary Cancer | Postoperative Pancreatic Fistula

Germany
Massachusetts General Hospital
Takeda

Recruiting

Biomarker for Infection Risk in CLL and MM

Multiple Myeloma | Chronic Lymphocytic Leukemia

United States
University of California, Davis
National Cancer Institute (NCI); IO Biotech

Recruiting

IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer

Stage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma

United States
Oslo University Hospital
Targovax ASA

Recruiting

The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma

Multiple Myeloma | Smoldering Multiple Myeloma

Norway
Fudan University

Recruiting

The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma (IRIS)

High-Risk Localized Soft Tissue Sarcoma

China
Tel-Aviv Sourasky Medical Center
Dana-Farber Cancer Institute

Recruiting

Predicting Progression of Developing Myeloma in a High-Risk Screened Population

Healthy

Israel
The First Affiliated Hospital with Nanjing Medical...
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Pyrotinib in Women With High-risk in Early Stage Breast Cancer

HER2-positive Breast Cancer

China
Imperial College London

Recruiting

Anal Cancer Risk In Women

Anal Cancer | Human Papilloma Virus | Anal Intraepithelial Neoplasia | Genital Neoplasm | Genital Cancer

United Kingdom
Fondazione del Piemonte per l'Oncologia

Recruiting

Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer (RETURN)

Prostate Cancer

Italy
Peking University People's Hospital
Peking University Cancer Hospital & Institute

Recruiting

Frontline of ASCT in High-risk DLBCL (Essential)

Diffuse Large B Cell Lymphoma

China

Search clinical trials for: Cancer Risk

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations